Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $815 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (LLY) and maintained a price target of $815.

February 20, 2024 | 5:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald maintains an Overweight rating on Eli Lilly with a price target of $815.
The reiteration of an Overweight rating and the maintenance of a high price target by a reputable analyst like Louise Chen from Cantor Fitzgerald could instill confidence among investors and potentially lead to a positive short-term impact on Eli Lilly's stock price. The specific mention of a substantial price target suggests a strong bullish outlook on the stock, which could influence investor sentiment positively.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100